The Chinese economy is tumbling down. To maximize the exports, Chinese pharma companies are targeting India to sell their bulk produce hampering Indian pharma companies’ sustenance. For a long time, low priced Chinese raw materials have helped the pharma companies of India to build generics industry and propel themselves as a global powerhouse of generic markets. Now those cheap raw material imports are turning out to be the largest headache for many pharma companies.
Indian pharma companies have been the largest consumer of Chinese producers of raw ingredients. Indian companies being the largest consumer of their produce, consume about 90% of the total manufactured products, directly or indirectly through intermediaries. This has worsened the situation for Indian pharma companies in bulk drug manufacturing, as they are now at a mercy of Chinese companies. The Chinese aggression in…
